Greenphire Recognized for Patient Engagement Innovation in 2021 MedTech Breakthrough Awards Program

May 06 2021

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

 KING OF PRUSSIA, Pa., – May 6, 2021Greenphire, the global leader in financial lifecycle management for clinical trials, announced that it has been selected as the winner of the “Best Overall Patient Engagement Service” award in the fifth annual MedTech Breakthrough Awards program, today. The award is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.

Greenphire is focused exclusively on improving the patient experience through financial automation. With over 11 million payments made to more than 2.6 million patients in nearly 30 countries, the company has become the industry leader in clinical trial patient engagement.

Once the COVID-19 pandemic hit, Greenphire surveyed clients to understand their pain points and used this feedback to shift their solution set, resulting in several breakthrough innovations, including enhancements to their globally adopted solutions, ClinCard and ConneX.

Greenphire’s ClinCard payment automation software streamlines participant reimbursements and stipends, eliminating financial hurdles that may keep participants from remaining enrolled in a clinical trial. Clinical trial participants receive funds in real-time via a reloadable debit card or direct deposit (and now introducing virtual ClinCards). ClinCard incorporates automated (local language) notifications via email or text message, including payment status and visit reminders, ensuring participants remain engaged throughout the study.

In 2020, sites were able to use ClinCard to pay patients remotely for activities such as virtual visits as well as for completing at-home eDiaries, keeping patients engaged and studies on-track. In fact, Greenphire’s overall number of patient payments grew 27% in 2020, despite the challenges felt across the industry in conducting clinical trials during the pandemic.

ConneX is the most comprehensive travel solution in the industry and designed to meet the unique needs of global clinical trials. With in-country and local language support, ConneX provides peace of mind by ensuring all travel details are taken care of (plane, train, hotel, car).

In 2020, the usage of ConneX expanded to enable in-home care through the delivery of medicines / equipment and transportation of medical staff to the participant to ensure that the medically fragile didn’t risk COVID-19 exposure to go to trial visits.

Additionally, for those participants who still needed in-person visits, Greenphire’s global travel coordinators ensured that cars were sanitized and cross-border travel was possible. As mass transportation and taxis presented increased risk, Greenphire’s rideshare service has been able to provide sanitized rides for patients to get to visits or labs. This service grew 237% in 2020 alone.

“Covid-19 brought a heightened awareness of clinical trials. In the past year our mission to increase patient convenience was as important as ever, reinforcing and accelerating trends toward participant centricity and solution adoption,” said Jim Murphy, CEO of Greenphire. “We are thankful our determination to help clinical trials remain on track and patient-centered is being recognized in such an important way by MedTech Breakthrough.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,850 nominations from over 17 different countries throughout the world.

“Creating awareness of research and removing patient barriers is essential for clinical trials and Greenphire is delivering breakthrough solutions to streamline the end-to-end financial side of clinical trials – from making payments, reimbursement and on to making reporting processes faster, easier, and more accurate,” said James Johnson, managing director, MedTech Breakthrough. “In a time where clinical trials are firmly set in the spotlight, Greenphire stepped up with breakthrough innovation and we offer our congratulations to Greenphire for winning our ‘Best Overall Patient Engagement Service’ award.”

This is the second year in a row that Greenphire has been honored by MedTechBreakthrough. In 2020, Greenphire earned accolades for being the “Best Patient Relationship Management Solution.”

####

About Greenphire

Greenphire is the leader in global clinical trial financial process automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s EnvisiXTM, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

 

About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

 

Join Our Mailing List